tiprankstipranks
Crispr Therapeutics price target lowered to $85 from $98 at BofA
PremiumThe FlyCrispr Therapeutics price target lowered to $85 from $98 at BofA
11d ago
Crispr Therapeutics call volume above normal and directionally bullish
Premium
The Fly
Crispr Therapeutics call volume above normal and directionally bullish
18d ago
Cathie Wood’s ARK Investment bought 58K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment bought 58K shares of Crispr Therapeutics today
22d ago
Cathie Wood’s ARK Investment bought 176K shares of Crispr Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment bought 176K shares of Crispr Therapeutics today
2M ago
Crispr Therapeutics management to meet with Piper Sandler
Premium
The Fly
Crispr Therapeutics management to meet with Piper Sandler
2M ago
Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics today
2M ago
Crispr Therapeutics reports Q3 EPS ($1.01), consensus ($1.42)
PremiumThe FlyCrispr Therapeutics reports Q3 EPS ($1.01), consensus ($1.42)
2M ago
Crispr Therapeutics options imply 8.9% move in share price post-earnings
Premium
The Fly
Crispr Therapeutics options imply 8.9% move in share price post-earnings
2M ago
CRSP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CRSP Earnings this Week: How Will it Perform?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100